Health·3,523 stories
Health News — Page 20
AMA CEO: AI Should Augment, Not Replace, Physicians
AMA CEO John Whyte argues in a STAT First Opinion essay that artificial intelligence should augment physicians rather than replace them, emphasizing that practicing medicine requires clinical responsi
Brigham ER: 152 Patients, 61 Rooms, AI Falls Short
STAT+ examines whether AI can fix health care, using a chaotic Brigham and Women's Hospital emergency department scene — where 152 patients in a waiting room overwhelmed a 61-room facility — to argue
Very hot drinks triple oesophageal cancer risk: study
The largest-ever study of hot drinks and oesophageal cancer, tracking nearly 980,000 UK adults for 14 years, found very hot tea and coffee triple the risk of squamous cell carcinoma of the oesophagus
Babies born to anaemic mothers have smaller brains, study finds
A study tracking more than 300 mothers and babies in Cape Town found infants born to anaemic mothers had brains 4% smaller on average, with the gap widening in key regions through age two.
Oxford Study: Very Hot Drinks Triple Oesophageal Cancer Risk
An Oxford University study of nearly a million people found regularly drinking tea or coffee at 65°C or above roughly triples the risk of oesophageal cancer, though the disease remains rare with about
Trigeminal nerve stimulation boosted memory in Leuven study
Researchers found that bursts of electrical stimulation to the trigeminal nerve via skin electrodes increased hippocampal signaling in rats and modestly improved occupation recall in healthy adults.
STAT+: UnitedHealth’s Democrat investment, and surprise billing bloat debate
UnitedHealth Group's top executives and board members, including CEO Stephen Hemsley, recently poured campaign donations into Rep. Katherine Clark of Massachusetts, the House's No. 2 Democrat, shortly
House Democrats outline health care agenda
House Democrats began sketching out a health care agenda during the brief week the House was in session, as Republicans canceled the final two weeks of September ahead of the Nov. 3 midterms.
Scientists discover a powerful new antivenom hidden in rattlesnake blood
University of Maryland researchers found that combining natural toxin-blocking proteins from western diamondback rattlesnake blood neutralizes venom from multiple viper species in lab tests — outperfo
Your personality may be more genetic than scientists realized
An international team identified more than 1,200 genetic variants linked to the Big Five personality traits, finding the same genetic patterns also connect to health, longevity, education, careers, an
STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more
Novartis's experimental drug del-desiran failed a pivotal Phase 3 trial — its second major flop in days — sending shares down as much as 10%, while Novo Nordisk halted two more trials of ziltivekimab
Ozempic Tied to 21% Lower Psychiatric Hospitalization Risk
A large Swedish study of nearly 15,000 people with bipolar disorder found that semaglutide, the active ingredient in Ozempic and Wegovy, was associated with a 21% lower risk of psychiatric hospitaliza
Team Observes Quantum Phase of Falling Atoms for First Time
Physicists have directly measured the quantum phase that gravity imprints on a falling atom for the first time, using an interferometer that split and reunited an atomic wave. Einstein's equivalence p
Two-Drug Combo Reverses Resistance in Prostate Cancer Study
University of Michigan researchers found that combining BET bromodomain and DNMT inhibitors reversed cellular identity changes in treatment-resistant prostate cancer and sharply slowed tumor growth in
Epigenome Editing Aims to Treat Disease Without Changing DNA
Geneticists are developing epigenome editing, a new approach that alters when and how genes are expressed rather than rewriting DNA, aiming to treat or prevent diseases driven by accumulated environme
Novartis stock sinks 12.5% as del-desiran flunks Phase 3
Novartis' del-desiran, the centerpiece asset of its $12 billion Avidity Biosciences acquisition, flunked its Phase 3 Harbor trial in myotonic dystrophy type 1, missing its primary endpoint and sending
Addenbrooke's Surgeon Harmed 209 Patients, One Died
A BBC investigation has revealed that suspended NHS orthopaedic surgeon Kuldeep Stohr caused harm to 209 patients at Addenbrooke's Hospital in Cambridge — 41 severely, with one death — prompting affec
Novartis Pelacarsen Miss Rattles Lp(a) Drug Race
Novartis's cholesterol drug pelacarsen lowered harmful Lp(a) levels in a late-stage cardiovascular trial but failed to reduce heart attacks and strokes, rattling a multibillion-dollar drug race that a
Scientists discover a hidden immune signal that helps spinal cords regrow
Researchers at TU Dresden have identified a subgroup of neutrophils that release the signaling molecule Il-4, calming inflammation and enabling zebrafish to regenerate damaged spinal cords — a finding
USC Study: PCE Exposure Triples Liver Fibrosis Risk
USC Keck Medicine researchers found that people with detectable levels of the dry-cleaning chemical tetrachloroethylene (PCE) in their blood were three times more likely to have significant liver fibr
Get the Health newsletter
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.